@article{article, title = {{Evaluation of Antitumor Activity Using Change in Tumor Size of the Survivin Antisense Oligonucleotide LY2181308 in Combination with Docetaxel for Second-Line Treatment of Patients with Non–Small-Cell Lung Cancer: A Randomized Open-Label Phase II Study}}, url = {{http://eprints.whiterose.ac.uk/110808/ }}, year = {{2014}}, month = {{11}}, author = {{Natale R and Blackhall F and Kowalski D and Ramlau R and Bepler G and Grossi F and Lerchenmüller C and Pinder-Schenck M and Mezger J and Danson S and Gadgeel SM et al}}, doi = {{10.1097/JTO.0000000000000285}}, volume = {{9}}, journal = {{Journal of Thoracic Oncology}}, issue = {{11}}, pages = {{1704-1708}}, note = {{Accessed on 2025/01/03}}}